Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #12887 on The Rising Influence of Rising Affluence
jbog
07/20/16 7:18 PM
#12890 RE: DewDiligence #12887
DewDiligence
10/19/16 4:20 PM
#13479 RE: DewDiligence #12887
The Company believes the anticipated "V-shaped" worldwide commodity recovery has begun. [It’s finally arrived!!] …Core Laboratories N.V. reported third quarter 2016 revenue of $143,500,000, down 3% sequentially from the second quarter 2016, with earnings per diluted share ("EPS") of $0.38, in accordance with U.S. generally accepted accounting principles ("GAAP"), flat from the second quarter 2016. Third quarter 2016 net income was $16,700,000; operating income was $21,500,000; and operating margins were 15%, all of which were up from the second quarter of 2016 as Core's cost reduction…and lab automation programs continue to produce positive financial results for the Company. Third quarter EPS and net income increased more significantly, 9% and 10%, respectively, when compared to the second quarter of 2016 non-GAAP results, which included removing the benefits of a lower than expected tax rate. …Fourth Quarter 2016 Revenue and EPS Guidance With international activity weaknesses being offset by North American activity increases, Core projects flat fourth quarter revenue ranging from between $143,000,000 and $145,000,000, and [GAAP] EPS to range between $0.38 and $0.40…